Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects

Journal of Medical Screening

Volumn 22, Issue 3, 2015, Pages 127-135

  Beckmann, Kerri ^a   Duffy, Stephen W ^b   Lynch, John ^c   Hiller, Janet ^d   Farshid, Gelareh ^e   Roder, David ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^e BreastScreen SA   (Australia)

Author keywords

Breast cancer; Mammography screening; Over diagnosis

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH SERVICE; HUMAN; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PREVALENCE; PROCEDURES; RADIOGRAPHY; RISK FACTOR; SOUTH AUSTRALIA; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; MAMMOGRAPHY; MASS SCREENING; MEDICAL OVERUSE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SOUTH AUSTRALIA; TIME FACTORS;

EID: 84944550673     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141315573978     Document Type: Article

References (39)

1. Paci E, Duffy S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005;7:266-70.
2. Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E. Overdiagnosis in mammography screening for breast cancer in Europe: a literature review. J Med Screen 2012;19(Suppl 1): 42-56.
3. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129-38.
4. de Gelder R, Heijnsdijk EAM, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ. Interpreting Overdiagnosis Estimates in Population-based Mammography Screening. Epidemiol. Rev 2011;33:111-21.
5. Duffy SW. Some current issues in breast cancer screening. J Med Screen 2005;12:128-33.
6. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH. Complexities in the estimation of overdiagnosis in breastcancer screening. Br J Cancer 2008;99:1176-8.
7. Duffy SW, Parmar D. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013;15:R41.
8. Zahl PH, Jorgensen KJ, Gotzsche PC. Lead-Time Models Should Not Be Used to Estimate Overdiagnosis in Cancer Screening. Journal of general internal medicine 2014;29:1283-6.
9. Paci E, Miccinesi G, Puliti D, Baldazzi P, De Lisi V, Falcini F, Cirilli C, Ferretti S, Mangone L, Finarelli AC, Rosso S, Segnan N, et al. Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy. Breast Cancer Res 2006;8:R68.
10. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 2004;11:23-7.
11. Australian Bureau of Statistics. 3101.0 - Australian Demographic Statisitics, June 2012 Canberra: ABS, 2012.
12. Australian Bureau of Statistics. Population Projections, Australia, 2012 (base) to 2101. Cat. no. 3222.0, Table C4, ed. 26/11/2013 Canberra: ABS, 2013.
13. Day NE. Estimating the sensitivity of a screening test. J Epidemiol Community Health 1985;39:364-6.
14. Day NE, Walter SD. Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984;40:1-14.
15. Silvey SD. Statistical Inferenceed. Harmondsworth. England: Penguin Books Ltd, 1970.
16. Beckmann KR, Farshid G, Roder DM, Hiller JE, Lynch JW.Impact of hormone replacement therapy use on mammographic screening outcomes. Cancer Causes Control 2013;24:1417-26.
17. Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, Roder DM. Anovel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. Int J Cancer 2015;136:1411-21.
18. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230-4.
19. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006;332:689-92.
20. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778-86.
21. Falk RS, Hofvind S, Skaane P, Haldorsen T. Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer 2013;133:705-12.
22. Waller M, Moss S, Watson J, Moller H. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev 2007;16:2257-61.
23. Puliti D, Miccinesi G, Zappa M, Manneschi G, Crocetti E, Paci E. Balancing harms and benefits of service mammography screening programs: a cohort study. Breast Cancer Res 2012;14:R9.
24. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166-71.
25. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25-30.
26. Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a populationbased mammography screening program. CMAJ 2013;185:E492-8.
27. Njor SH, Olsen AH, Blichert-Toft M, Schwartz W, Vejborg I, Lynge E. Overdiagnosis in screening mammography in Denmark: population based cohort study. BMJ 2013;346:f1064.
28. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168:2311-6.
29. Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2010;21:275-82.
30. Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. Br. Med. J 2009;339:b2587.
31. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012;156:491-9.
32. Zahl PH, Maehlen J. Overdiagnosis of breast cancer after 14 years of mammography screening. Tidsskr Nor Laegeforen 2012;132:414-7.
33. Beckmann K, Roder D, Hiller JE, Farshid G, Lynch J. The influence of mammographic screening on breast cancer incidence trends in South Australia. Asia Pac J Cancer Prev 2014;15:3105-12.
34. Chittleborough CR, Grant JF, Phillips PJ, Taylor AW. The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesity. Public Health 2007;121:92-9.
35. Taylor AW, MacLennan AH, Avery JC. Postmenopausal hormone therapy: who now takes it and do they differ from non-users? AustNZ J Obstet Gynaecol 2006;46:128-35.
36. Taylor R, Boyages J. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening. J Med Screen 2001;8:73-6.
37. Nassar A. Core needle biopsy versus fine needle aspiration biopsy in breast-a historical perspective and opportunities in the modern era. Diagnostic cytopathology 2011;39:380-8.
38. Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S. Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res 2008;10:R41.
39. Zahl PH, Jorgensen KJ, Gotzsche PC. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer 2013;109:2014-9.